Machine learning techniques to predict diabetic ketoacidosis and HbA1c above 7% among individuals with type 1 diabetes - A large multi-centre study in Australia and New Zealand.

Nutr Metab Cardiovasc Dis

Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Aims: Type 1 diabetes and diabetic ketoacidosis (DKA) have a significant impact on individuals and society across a wide spectrum. Our objective was to utilize machine learning techniques to predict DKA and HbA1c>7 %.

Methods And Results: Nine different models were implemented and model performance evaluated via the Area under the Curve (AUC). These models were applied to a large multi-centre dataset of 13761 type 1 diabetes individuals prospectively recruited from Australia and New Zealand. Predictive features included a number of clinical demographic and socio-economic measures collected at previous visits. In our study, 2.9 % reported at least one episode of DKA since their last clinic visit. A number of features were significantly associated with DKA. Our results showed that Deep Learning (DL) model performed well in predicting DKA with an AUC of 0.887. The DL also provided the lowest classification error rate of 0.9 %, highest sensitivity of 99.9 % and F-measure of 99.6 %. As for HbA1c >7 %, the optimal Support Vector Machine provided a good AUC of 0.884.

Conclusion: Machine learning models can be effectively implemented on real-life large clinical datasets and they perform well in terms of identifying individuals with type 1 diabetes at risk of adverse outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2025.103861DOI Listing

Publication Analysis

Top Keywords

type diabetes
16
machine learning
12
learning techniques
8
techniques predict
8
diabetic ketoacidosis
8
individuals type
8
large multi-centre
8
australia zealand
8
dka
5
machine
4

Similar Publications

Background: Cardio-kidney-metabolic (CKM) disease represents a significant public health challenge. While proteomics-based risk scores (ProtRS) enhance cardiovascular risk prediction, their utility in improving risk prediction for a composite CKM outcome beyond traditional risk factors remains unknown.

Methods: We analyzed 23 815 UK Biobank participants without baseline CKM disease, defined by -Tenth Revision codes as cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral arterial disease, atrial fibrillation/flutter), kidney disease (chronic kidney disease or end-stage renal disease), or metabolic disease (type 2 diabetes or obesity).

View Article and Find Full Text PDF

Aims: Chronic ocular diseases such as age-related macular degeneration (AMD) are leading causes of vision loss in older adults. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely prescribed in the management of type 2 diabetes mellitus (T2DM), their effects on ocular disease risk remain largely unknown.

Materials And Methods: This retrospective cohort study evaluated the association between SGLT2i use and the risk of AMD and other age-related ocular conditions in adults aged ≥60 with T2DM, using a target trial emulation framework based on the TriNetX global health research network (2013-2025).

View Article and Find Full Text PDF

Non-ST elevation myocardial infarction with multivessel disease and anoxic brain injury: a case report.

Future Cardiol

September 2025

Department of Internal Medicine, Valley Health System Graduate Medical Education, Las Vegas, NV, USA.

A 71-year-old black male with a history of hypertension, dyslipidemia, type 2 diabetes, history of bladder cancer status-post resection now in remission, history of multiple transient ischemic attacks, and coronary artery disease (CAD) presented with non-exertional substernal chest pain radiating to the left arm, accompanied by shortness of breath and nausea. Initial evaluation revealed elevated troponins and nonspecific electrocardiogram changes, consistent with non-ST elevation myocardial infarction. Coronary angiography demonstrated severe multivessel disease, including critical left main stenosis.

View Article and Find Full Text PDF

This study was designed to investigate the switch between the open-source automated insulin delivery (OS-AID) system AndroidAPS (AAPS) and commercially available AID systems Control-IQ (CIQ) and MiniMed 780G (780G) conducted in a new extended follow-up study. In this prospective open-label single-arm clinical trial, 41 adults with type 1 diabetes (age 35 ± 11 years, glycated hemoglobin [HbA1c] 6.4 ± 2.

View Article and Find Full Text PDF